BR0011999A - Formas de dosagem farmacêutica para liberação controlada produzindo pelo menos um pulso cronometrado - Google Patents

Formas de dosagem farmacêutica para liberação controlada produzindo pelo menos um pulso cronometrado

Info

Publication number
BR0011999A
BR0011999A BR0011999-7A BR0011999A BR0011999A BR 0011999 A BR0011999 A BR 0011999A BR 0011999 A BR0011999 A BR 0011999A BR 0011999 A BR0011999 A BR 0011999A
Authority
BR
Brazil
Prior art keywords
dosage forms
pharmaceutical dosage
controlled release
timed pulse
producing
Prior art date
Application number
BR0011999-7A
Other languages
English (en)
Inventor
Frederic Andre
Gareth Lewis
Jerome Mignonneau
Agnes Ribardiere
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of BR0011999A publication Critical patent/BR0011999A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: "FORMAS DE DOSAGEM FARMACêUTICA PARA LIBERAçãO CONTROLADA PRODUZINDO PELO MENOS UM PULSO CRONOMETRADO". A presente invenção refere-se a núcleos revestidos para liberação prolongada compreendendo uma substância ativa em seu núcleo e um revestimento polimérico compreendendo pelo menos um ou mais copolímeros de metacrilato de amónio, caracterizado pelo fato de que o núcleo compreende pelo menos um tensoativo; a formas de dosagem farmacêuticas monolíticas ou multiparticuladas, compreendendo tais núcleos de liberação prolongada e a seu método de produção.
BR0011999-7A 1999-06-28 2000-06-27 Formas de dosagem farmacêutica para liberação controlada produzindo pelo menos um pulso cronometrado BR0011999A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99401606A EP1064938A1 (en) 1999-06-28 1999-06-28 Pharmaceutical dosage forms for controlled release producing at least a timed pulse
PCT/EP2000/006795 WO2001000182A1 (en) 1999-06-28 2000-06-27 Pharmaceutical dosage forms for controlled release producing at least a timed pulse

Publications (1)

Publication Number Publication Date
BR0011999A true BR0011999A (pt) 2002-03-05

Family

ID=8242029

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011999-7A BR0011999A (pt) 1999-06-28 2000-06-27 Formas de dosagem farmacêutica para liberação controlada produzindo pelo menos um pulso cronometrado

Country Status (29)

Country Link
US (1) US20080175910A1 (pt)
EP (2) EP1064938A1 (pt)
JP (1) JP2003503341A (pt)
KR (1) KR100794402B1 (pt)
CN (2) CN101669914A (pt)
AR (1) AR024492A1 (pt)
AT (1) ATE274902T1 (pt)
AU (1) AU780769B2 (pt)
BR (1) BR0011999A (pt)
CA (1) CA2370067C (pt)
CO (1) CO5190681A1 (pt)
CZ (1) CZ296067B6 (pt)
DE (1) DE60013445T2 (pt)
DK (1) DK1194131T3 (pt)
ES (1) ES2225183T3 (pt)
HK (1) HK1043056B (pt)
HU (1) HU229312B1 (pt)
IL (2) IL146768A0 (pt)
MX (1) MXPA01013408A (pt)
NO (1) NO332952B1 (pt)
NZ (1) NZ515826A (pt)
PL (1) PL200816B1 (pt)
PT (1) PT1194131E (pt)
SI (1) SI1194131T1 (pt)
SK (1) SK285359B6 (pt)
TR (1) TR200103604T2 (pt)
TW (1) TWI242451B (pt)
WO (1) WO2001000182A1 (pt)
ZA (1) ZA200109849B (pt)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0501071A3 (en) 2001-03-13 2007-06-28 Penwest Pharmaceutical Co Chronotherapeutic dosage forms
DE10149674A1 (de) 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
ZA200403281B (en) * 2001-11-07 2005-12-13 Synthon Bv Tamsulosin tablets.
WO2003045437A1 (en) * 2001-11-30 2003-06-05 Pfizer Products Inc. Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
JP4417110B2 (ja) * 2001-12-19 2010-02-17 株式会社三和化学研究所 放出制御型成型品
CA2491355A1 (en) * 2002-07-05 2004-01-15 Temrel Limited Controlled release compositions comprising coated pellets having non-uniform coating thicknesses
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
BR0315569A (pt) * 2002-10-22 2005-08-30 Ranbaxy Lab Ltd Apresentação farmacêutica de liberação prolongada contendo alfuzosina
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
KR100592512B1 (ko) * 2002-11-22 2006-07-03 서울약품공업(주) 탐술로신 또는 약제학적으로 허용되는 이의 염을활성성분으로 하는 서방성 배뇨장애 치료제
IN192381B (pt) * 2002-12-20 2004-04-10 Ranbaxy Lab
EP1663156A2 (en) * 2003-09-19 2006-06-07 Penwest Pharmaceuticals Company Chronotherapeutic dosage forms
CA2539051C (en) * 2003-09-19 2014-08-12 Penwest Pharmaceuticals Co. Delayed release dosage forms
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
KR100436701B1 (ko) * 2003-11-07 2004-06-22 주식회사 씨티씨바이오 염산 탐스로신 함유 방출 조절형 제제 및 그의 제조방법
US8292729B2 (en) 2003-12-02 2012-10-23 United Tote Company Methods and systems for presenting pari-mutuel betting options and constructing wagers
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
AR052225A1 (es) * 2004-11-04 2007-03-07 Astrazeneca Ab Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones
AR051654A1 (es) * 2004-11-04 2007-01-31 Astrazeneca Ab Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
JP2008524332A (ja) * 2004-12-20 2008-07-10 コレジウム ファーマシューティカル， インク． 睡眠傷害のための医薬組成物
CA2595885A1 (en) * 2005-01-26 2006-08-03 Elan Pharma International Limited Controlled release compositions comprising an antipsychotic agent
BRPI0609505A2 (pt) * 2005-03-29 2010-04-13 Rihm Gmbh forma farmacêutica em multipartìculas compreendendo péletes com uma matriz que influencia o fornecimento de uma substáncia moduladora
WO2007080509A2 (en) 2006-01-12 2007-07-19 Wockhardt Ltd Sustained release compositions of alfuzosin
US20070292505A1 (en) * 2006-06-15 2007-12-20 Abrika Pharmaceuticals, Inc. Controlled release alfuzosin hydrochloride formulation
US20080095844A1 (en) * 2006-10-23 2008-04-24 Rajhans Sujay Kamalakar Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof
CN101269056B (zh) * 2007-03-19 2010-05-19 天津药物研究院 一种美托洛尔盐类口服脉冲微丸制剂
US8178483B2 (en) * 2007-03-30 2012-05-15 Colgate-Palmolive Company Polymeric encapsulates having a quaternary ammonium salt and methods for producing the same
JP5228359B2 (ja) * 2007-04-12 2013-07-03 ニプロ株式会社 主薬粒子及びその製造方法ならびに口腔内崩壊錠
FR2928929B1 (fr) * 2008-03-19 2012-01-13 Saint Gobain Composition serigraphiable sur polyvinylbutyral
CN102548544B (zh) * 2009-10-09 2015-01-21 永进药品工业株式会社 同时具有速效特性和长效特性的药物组合物
CN102106841B (zh) * 2009-12-24 2013-01-09 杭州康恩贝制药有限公司 一种盐酸坦洛新制剂及其制备方法
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
MX341200B (es) 2010-03-29 2016-08-11 Ferring Bv Composicion farmaceutica de disolucion rapida.
KR101686033B1 (ko) * 2010-04-12 2016-12-13 주식회사 대웅제약 탐술로신 또는 이의 약제학적 허용 가능한 염을 유효성분으로 함유하는 장용성 서방형 펠렛부와 속방부로 이루어진 의약 조성물
WO2011144994A1 (en) * 2010-05-21 2011-11-24 Lupin Limited Pharmaceutical compositions of nsaid and acid inhibitor
US8623409B1 (en) 2010-10-20 2014-01-07 Tris Pharma Inc. Clonidine formulation
TW201422254A (zh) * 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
JP7011830B2 (ja) 2015-10-14 2022-01-27 エックス－サーマ インコーポレイテッド 氷晶形成を低減するための組成物および方法
CN105362233A (zh) * 2015-12-07 2016-03-02 黑龙江省智诚医药科技有限公司 一种卡托普利缓释微丸及其制备方法
US10849856B2 (en) 2016-10-31 2020-12-01 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same
DK3337462T3 (da) 2016-10-31 2020-10-12 Neurim Pharma 1991 Melatonin-minitabletter og fremgangsmåde til fremstilling heraf
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion
CN107233328A (zh) * 2017-06-13 2017-10-10 江苏黄河药业股份有限公司 卡托普利缓释片剂及其制备方法
CN107362161B (zh) * 2017-08-14 2020-05-29 黄河科技学院 一种复方卡托普利硝苯地平脉冲缓释制剂及其制备方法
TR201721036A2 (tr) 2017-12-21 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbi̇profeni̇n modi̇fi̇ye salimli formülasyonlari
JP7162330B2 (ja) * 2018-07-11 2022-10-28 株式会社アタゴ 粘度計
CN110075090A (zh) * 2019-05-17 2019-08-02 南京望知星医药科技有限公司 一种用于治疗呼吸疾病的沙丁胺醇胶囊及其制备方法
CN110037994B (zh) * 2019-05-24 2022-04-12 中国药科大学 一种布洛芬速释缓释双层片及其制备方法
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US4677099A (en) * 1981-09-04 1987-06-30 Yeda Research And Development Co., Ltd. Medical processes employing a novel lipid fraction
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
JPS58116414A (ja) * 1981-12-23 1983-07-11 Yamanouchi Pharmaceut Co Ltd ニカルジピン持続性製剤用球形顆粒およびその製造法
US4614796A (en) * 1983-03-25 1986-09-30 Nippon Shinyaku Co., Ltd. Liposome and method of manufacture therefor
EP0212746B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release
US4986987A (en) * 1986-05-09 1991-01-22 Alza Corporation Pulsed drug delivery
US4994273A (en) * 1987-11-02 1991-02-19 Merck & Co., Inc. Solubility modulated drug delivery device
ES2077023T3 (es) * 1989-03-10 1995-11-16 Yamanouchi Pharma Co Ltd Material de recubrimiento que controla la liberacion de un medicamento para formulaciones de actividad prolongada.
US5176901A (en) * 1991-04-10 1993-01-05 Smithkline Beecham Corporation Dental composition
EP0546593B1 (en) * 1991-10-30 1997-09-03 Glaxo Group Limited Multi-layered compositions containing histamine or serotonin antagonists
HU227530B1 (en) * 1991-11-22 2011-07-28 Warner Chilcott Company Delayed-release compositions containing risedronate and process for their production
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
KR0168715B1 (ko) * 1992-11-30 1999-01-15 밋첼 아이. 커시너 맛을 차단하는 약제학적 조성물
CA2161538A1 (en) * 1993-07-22 1995-02-02 S. Shirley Yang Controlled release tacrine drug delivery systems and methods for preparing same
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
US6020375A (en) * 1997-06-13 2000-02-01 Senju Pharmaceutical Co., Ltd. Bactericidal composition
BR9802915A (pt) * 1997-09-12 2000-01-11 Oscar Gold Procedimento para formar composições farmaceuticas em pilulas ou granulos substancialmente esfericos, de ação controlada e continuada, contendo como agente ativo o (7-bromo-1,3-diidro-5-(2-piridninilo)-2h-1,4-benzodiazep ina-2(1h)-um)
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
DK173431B1 (da) * 1998-03-20 2000-10-23 Gea Farmaceutisk Fabrik As Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
US6124362A (en) * 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth
US6270805B1 (en) * 1998-11-06 2001-08-07 Andrx Pharmaceuticals, Inc. Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6495498B2 (en) * 1999-05-27 2002-12-17 Johnson & Johnson Consumer Companies, Inc. Detergent compositions with enhanced depositing, conditioning and softness capabilities

Also Published As

Publication number Publication date
ZA200109849B (en) 2003-02-26
NO20016282L (no) 2002-02-27
SK19102001A3 (sk) 2002-05-09
EP1194131A1 (en) 2002-04-10
AR024492A1 (es) 2002-10-02
AU780769B2 (en) 2005-04-14
TR200103604T2 (tr) 2002-04-22
CA2370067A1 (en) 2001-01-04
HK1043056B (zh) 2005-04-29
JP2003503341A (ja) 2003-01-28
HUP0202259A2 (hu) 2002-12-28
MXPA01013408A (es) 2002-07-30
IL146768A (en) 2010-05-17
SI1194131T1 (en) 2005-04-30
HUP0202259A3 (en) 2004-05-28
HK1043056A1 (en) 2002-09-06
PL354399A1 (en) 2004-01-12
DE60013445T2 (de) 2005-09-01
NZ515826A (en) 2004-04-30
KR20020015065A (ko) 2002-02-27
CZ296067B6 (cs) 2006-01-11
NO20016282D0 (no) 2001-12-20
ES2225183T3 (es) 2005-03-16
CO5190681A1 (es) 2002-08-29
ATE274902T1 (de) 2004-09-15
EP1194131B1 (en) 2004-09-01
WO2001000182A1 (en) 2001-01-04
CZ20014639A3 (cs) 2002-04-17
CN1358088A (zh) 2002-07-10
DK1194131T3 (da) 2005-01-17
US20080175910A1 (en) 2008-07-24
TWI242451B (en) 2005-11-01
DE60013445D1 (de) 2004-10-07
IL146768A0 (en) 2002-07-25
EP1064938A1 (en) 2001-01-03
AU6274700A (en) 2001-01-31
PT1194131E (pt) 2005-01-31
SK285359B6 (sk) 2006-11-03
HU229312B1 (hu) 2013-10-28
KR100794402B1 (ko) 2008-01-16
CA2370067C (en) 2009-07-28
NO332952B1 (no) 2013-02-11
CN101669914A (zh) 2010-03-17
PL200816B1 (pl) 2009-02-27

Similar Documents

Publication Publication Date Title
BR0011999A (pt) Formas de dosagem farmacêutica para liberação controlada produzindo pelo menos um pulso cronometrado
BR0207932A (pt) Composições farmacêuticas de sabor mascarado
BR9814375A (pt) Inibição de raf cinase usando difenil uréias substituìdas simétricas e assimétricas
DE60118395D1 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen
DE69434479D1 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
BR0215262A (pt) Formas de dosagem com liberação sustentada de ordem zero e processo para a fabricação das mesmas
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
DE60232147D1 (de) Pharmazeutische zubereitung mit verzögerter wirkstoff-freisetzung enthaltend milchsäure-glycolsäure copolymer, und verfahren zu deren herstellung
BR0113520A (pt) Processo de preparação de ácidos n-aril-antranìlicos e seus derivados
EP0327295A3 (en) Tetracycline dosage form
GEP20053447B (en) Antibiotic Preparation with Retarding Active Ingredient Release
ITRM930518A0 (it) Metodo per la fabbricazione di articolo impiegando anima non di sabbiae articolo prodotto con questa, e struttura di anima
FR2816507B1 (fr) Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
DE69001573D1 (de) Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
ES2180774T3 (es) La utilizacion de triacetato de glicerilo para el tratamiento de onicomicosis.
FR2774910B1 (fr) Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques
WO2002053149A3 (de) Arzneimittel enthaltend ein polyamin als wirksubstanz
DE50211212D1 (de) Pharmazeutische zubereitung enthaltend wirkstoffe aus den pflanzen centella asiatica, mahonia aquifolium und viola tricolor
WO1998031712A3 (en) Chitosan-conjugates with acidic chelate-complex forming agents
ATE236621T1 (de) Niedrig dosierte tabletten, und verfahren zur herstellung
BR9915835A (pt) Composição farmacêutica, e, processo para a preparação de uma composição
CA2399856A1 (en) Antibiotic composition with inhibitor
BR9609804A (pt) Processo para a preparação de formas farmacéuticas sólidas com drogas de dosagens muíto baixas
ES2155131T3 (es) Proceso para la fabricacion de dispositivos para la liberacion controlada de principios activos.
DE69632338D1 (de) Neue aminosäurederivate, die eine n, n-dialkylaminophenylgruppe haben

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 9/50

Ipc: A61K 9/50 (2009.01), A61K 9/32 (2009.01), A61K 9/5

B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: POR MEIO DA PETICAO INPI/RJ NO 020090118753, DE 18/12/2009, A REQUERENTE APRESENTOU MANIFESTACAO EM RELACAO AO PARECER TECNICO NOTIFICADO NA RPI 2020, DE 22/09/2009, E, EM ANEXO NOVAS VIAS DAS PAGINAS 1, 1A, 5, 6 E 10 DO RELATORIO DESCRITIVO, NOVAS VIAS DAS PAGINAS 1 DO RESUNO E NOVAS VIAS DO QUADRO REIVINDICATORIO, O QUAL E COMPOSTO DE 6 PAGINAS E 27 REIVINDICACOES. NESTA MESMA PETICAO, CONSTA O PAGAMENTO REFERENTE AO SERVICO DE CUMPRIMENTO DE EXIGENCIA ( 6.1 ). CONFORME PODE SER VERIFICADO NA PETICAO INPI/RJ NO 033834, DE 23/06/2003, O PEDIDO DE EXAME DO PRESENTE FOI FEITO MEDIANTE A RETRIBUICAO REFERENTE A 22 REIVINDICACOES. ENTRETANTO, O QUADRO REIVINDICATORIO AGORA APRESENTADO POS

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 16A ANUIDADE.

B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time